Brief: Avrobio Receives Rare Pediatric Disease Designation From The U.S. FDA For First-In-Class Gene Therapy For Gaucher Disease

Tectonic Therapeutic

27/10/2022 12:54

Oct 27 (Reuters) - AVROBIO Inc  AVRO.O :
    * AVROBIO RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM
THE
U.S. FDA FOR FIRST-IN-CLASS GENE THERAPY FOR GAUCHER DISEASE

Source text for Eikon:  ID:nBwbTRVR7a 
Further company coverage:  AVRO.O 
 ((Reuters.Briefs@thomsonreuters.com;))